Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Severe weather warning in your area. Please stay indoors and stay safe. Read more
regimen
APAL
Cancer Type
Genitourinary,
Prostate
Intent
Palliative
Regimen Category
Evidence-Informed
Funding Program
High Cost Therapy Funding Program
apalutamide - Sep 2026 UAT Testing HCTFP
Exceptional Access Program
apalutamide - For the treatment of metastatic castration sensitive prostate cancer (mCSPC), based on criteria
Drugs in Regimen
Regimen Monograph
UPDATED
Sep 2026
Patient Info Sheet
Please see Drugs Used for related Patient Information Sheets. Patient Information Sheets are not yet available for this regimen.
Last Updated: August 12, 2026
